共 50 条
- [1] First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: A phase II studyBMC CANCER, 2005, 5 (1)Allouache, DGawande, SRTubiana-Hulin, MTubiana-Mathieu, NPiperno-Neumann, SMefti, FBozec, LGenot, JY
- [2] Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancerSEMINARS IN ONCOLOGY, 1997, 24 (05) : 35 - 39Luck, HJThomssen, CduBois, AUntch, MLisboa, BKohler, GDiergarten, K
- [3] Phase II trial of weekly docetaxel/gemcitabine as first-line chemotherapy in patients with locally recurrent or metastatic breast cancerCLINICAL BREAST CANCER, 2006, 6 (06) : 505 - 510O'Shaughnessy, Joyce A.Pluenneke, RobertSternberg, JackKhandelwal, PankajIlegbodu, DesAsmar, Lina
- [4] A Randomized Phase II Study of Paclitaxel and Bevacizumab With and Without Gemcitabine as First-Line Treatment for Metastatic Breast CancerCLINICAL BREAST CANCER, 2011, 11 (04) : 211 - 220Brufsky, AdamHoelzer, KarenBeck, ThaddeusWhorf, RobertKeaton, MarkNadella, PadmaKrill-Jackson, ElisaKroener, JoanMiddleman, EdwardFrontiera, MichaelPaul, DevchandPanella, TimothyBromund, JaneZhao, LupingOrlando, MauroTai, FritzMarciniak, Martin D.Obasaju, ColemanHainsworth, John
- [5] Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trialONCOLOGY, 2002, 62 (01) : 2 - 8Blackstein, MVogel, CLAmbinder, RCowan, JIglesias, JMelemed, A
- [6] A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancerMEDICINE, 2021, 100 (20) : E26052Fukahori, MasaruMiwa, KeisukeMurotani, KentaNaito, YoshikiUshijima, TomoyukiSakaue, TakahikoTanaka, ToshimitsuNagasu, SachikoSuga, HideyaKakuma, TatsuyukiOkabe, YoshinobuTorimura, Takuji
- [7] Preliminary results of a randomized phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)Hoelzer, K. L.Brufsky, A.Hainsworth, J.Beck, J. T.Whorf, R.Keaton, M.Kroener, J.Krill-Jackson, E.Hu, S.Bromund, J.
- [8] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancerJOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390Blum, Joanne L.Dees, E. ClaireChacko, AparnaDoane, LisaEthirajan, SukumarHopkins, JudithMcMahon, RichardMerten, SuzanNegron, AngelNeubauer, MarcusIlegbodu, DesBoehm, Kristi A.Asmar, LinaO'Shaughnessy, Joyce A.
- [9] Interim analysis of a phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancerSEMINARS IN ONCOLOGY, 1996, 23 (01) : 33 - 36Luck, HJThomssen, CduBois, ALisboa, BWUntch, MKuhnle, HKonecny, GJanicke, FMeerpohl, HGLindner, CHecker, DDiergarten, K
- [10] Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experienceBMC CANCER, 2006, 6 (1)Passardi, AMassa, IZoli, WGianni, LMilandri, CZumaglini, FNanni, OMaltoni, RFrassineti, GLAmadori, D